PLRX
Pliant Therapeutics·NASDAQ
--
--(--)
--
--(--)
PLRX fundamentals
Pliant Therapeutics (PLRX) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.71 (YoY +22.83%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.71
+22.83%
Report date
Aug 7, 2025
EPS
Actual | -1.39 | -0.47 | -0.54 | -0.64 | -0.64 | -0.75 | -0.68 | -0.78 | -0.82 | -0.65 | -0.72 | -0.67 | -0.7 | -0.7 | -0.69 | -0.78 | -0.92 | -0.95 | -0.82 | -0.92 | -0.71 |
Forecast | -0.8583 | -0.8486 | -0.7124 | -0.6047 | -0.6702 | -0.6904 | -0.7607 | -0.7494 | -0.8124 | -0.7412 | -0.7 | -0.6683 | -0.7132 | -0.7753 | -0.8135 | -0.7718 | -0.8486 | -0.9692 | -0.9564 | -0.7668 | -0.6772 |
Surprise | -61.95% | +44.61% | +24.20% | -5.84% | +4.51% | -8.63% | +10.61% | -4.08% | -0.94% | +12.30% | -2.86% | -0.25% | +1.85% | +9.71% | +15.18% | -1.06% | -8.41% | +1.98% | +14.26% | -19.98% | -4.84% |
Revenue
Actual | 3.60M | 4.81M | 4.46M | 2.17M | 1.79M | 1.61M | 2.00M | 1.25M | 4.99M | 1.48M | 1.97M | 1.33M | 248.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 3.70M | 2.50M | 3.37M | 4.23M | 4.17M | 3.17M | 3.00M | 1.26M | 1.35M | 1.79M | 1.45M | 1.39M | 1.21M | 1.02M | 814.11K | 580.63K | 732.50K | 472.22K | 0 | 0 | 0 |
Surprise | -2.70% | +92.56% | +32.62% | -48.65% | -57.06% | -49.16% | -33.37% | -0.87% | +269.59% | -17.32% | +35.46% | -4.02% | -79.55% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Pliant Therapeutics’s earnings call?Did Pliant Therapeutics beat or miss consensus estimates last quarter?What is Pliant Therapeutics's gross profit margin?What were the key takeaways from Pliant Therapeutics's earnings call?What is the market's earnings forecast for Pliant Therapeutics next quarter?What does Pliant Therapeutics do and what are its main business segments?What is Pliant Therapeutics's latest dividend and current dividend yield?What factors drove the changes in Pliant Therapeutics's revenue and profit?
